Jeffrey S. Mathiesen
Director · NEUROONE MEDICAL TECHNOLOGIES Corp
Individual
- 2025
- Apr 7, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey S. Mathiesen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David J. Wambeke - $737K in NMTC purchases and sales in the last 12 months
- Mark Christianson - $55K in NMTC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey S. Mathiesen?
Jeffrey S. Mathiesen is a corporate insider, tracked as Director of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jeffrey S. Mathiesen last file a Form 4?
The most recent primary Form 4 on record is dated 7 April 2026, one of 3 filings going back to 2025.
